1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Mixed amphetamine salts |
| brand | String | Adderall, Adderall XR, Mydayis |
| structure | File |  Amphetamine-white.svg |
| classes | List of String, delimiter: , | Psychostimulant • Amphetamine |
| mechanism | String | TAAR1 agonism, VMAT2 substrate, DAT/NET reverse transport, net release of dopamine and norepinephrine |
| uses | String | '"`UNIQ--vote-00000562-QINU`"', '"`UNIQ--vote-00000563-QINU`"', '"`UNIQ--vote-00000564-QINU`"', '"`UNIQ--vote-00000565-QINU`"', '"`UNIQ--vote-00000566-QINU`"' |
| starting_dose | String | 2.5 mg IR, 5 mg XR, or 12.5mg Mydayis |
| preparations | String | IR tabs 5, 7.5, 10, 12.5, 15, 20, 30 mg; XR caps 5, 10, 15, 20, 25, 30 mg; Mydayis caps 12.5, 25, 37.5, 50 mg |
| fda_max | String | XR = 40 or 60 mg/d; IR = 40 or 60 mg/d'"`UNIQ--ref-00000567-QINU`"' |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | IR: 30–60 min; XR: 1–2 h to peak effect |
| duration | String | IR 4–6 h; XR 10–12 h; Mydayis 14–16 h |
| halflife | String | D-amphetamine ~10 h; L-amphetamine ~13 h (adults) |
| bioavailability | String | ~75–90% (oral) |
| pregnancy | String | Category C |
| legal | String | Schedule II |
